Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))

Jill Gilbert; Michelle A. Rudek; Michaela J. Higgins; Ming Zhao; Sara Bienvenu; Nancy Tsottles; Muhammad A. Chaudhry; Richard L Wahl; Arlene A. Forastiere; Maura Gillison

doi:10.1158/1078-0432.CCR-12-1736

Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))

Jill Gilbert, Michelle A. Rudek, Michaela J. Higgins, Ming Zhao, Sara Bienvenu, Nancy Tsottles, Muhammad A. Chaudhry, Richard L Wahl, Arlene A. Forastiere, Maura Gillison

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	3998
Number of pages	1
Journal	Clinical Cancer Research
Volume	18
Issue number	14
DOIs	https://doi.org/10.1158/1078-0432.CCR-12-1736
State	Published - Jul 15 2012

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-12-1736

Cite this

Gilbert, J., Rudek, M. A., Higgins, M. J., Zhao, M., Bienvenu, S., Tsottles, N., Chaudhry, M. A., Wahl, R. L., Forastiere, A. A., & Gillison, M. (2012). Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742)). Clinical Cancer Research, 18(14), 3998. https://doi.org/10.1158/1078-0432.CCR-12-1736

Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742)). / Gilbert, Jill; Rudek, Michelle A.; Higgins, Michaela J. et al.
In: Clinical Cancer Research, Vol. 18, No. 14, 15.07.2012, p. 3998.

Research output: Contribution to journal › Comment/debate › peer-review

Gilbert, J, Rudek, MA, Higgins, MJ, Zhao, M, Bienvenu, S, Tsottles, N, Chaudhry, MA, Wahl, RL, Forastiere, AA & Gillison, M 2012, 'Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))', Clinical Cancer Research, vol. 18, no. 14, pp. 3998. https://doi.org/10.1158/1078-0432.CCR-12-1736

@article{a3a33d1dc1084c97beb06ad14e08d13d,

title = "Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))",

author = "Jill Gilbert and Rudek, {Michelle A.} and Higgins, {Michaela J.} and Ming Zhao and Sara Bienvenu and Nancy Tsottles and Chaudhry, {Muhammad A.} and Wahl, {Richard L} and Forastiere, {Arlene A.} and Maura Gillison",

year = "2012",

month = jul,

day = "15",

doi = "10.1158/1078-0432.CCR-12-1736",

language = "English (US)",

volume = "18",

pages = "3998",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "14",

}

TY - JOUR

T1 - Correction

T2 - A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))

AU - Gilbert, Jill

AU - Rudek, Michelle A.

AU - Higgins, Michaela J.

AU - Zhao, Ming

AU - Bienvenu, Sara

AU - Tsottles, Nancy

AU - Chaudhry, Muhammad A.

AU - Wahl, Richard L

AU - Forastiere, Arlene A.

AU - Gillison, Maura

PY - 2012/7/15

Y1 - 2012/7/15

UR - http://www.scopus.com/inward/record.url?scp=84863969009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863969009&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-12-1736

DO - 10.1158/1078-0432.CCR-12-1736

M3 - Comment/debate

AN - SCOPUS:84863969009

SN - 1078-0432

VL - 18

SP - 3998

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 14

ER -

Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this